Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

1.

Optimal experimental designs for dose-response studies with continuous endpoints.

Holland-Letz T, Kopp-Schneider A.

Arch Toxicol. 2014 Aug 26. [Epub ahead of print]

PMID:
25155192
[PubMed - as supplied by publisher]
2.

Efficacy and toxicity of chemoradiation in patients with anal cancer--a retrospective analysis.

Koerber SA, Slynko A, Haefner MF, Krug D, Schoneweg C, Kessel K, Kopp-Schneider A, Herfarth K, Debus J, Sterzing F.

Radiat Oncol. 2014 May 13;9:113. doi: 10.1186/1748-717X-9-113.

PMID:
24886574
[PubMed - in process]
Free PMC Article
3.

Magnetic resonance imaging detects changes in structure and perfusion, and response to therapy in early cystic fibrosis lung disease.

Wielpütz MO, Puderbach M, Kopp-Schneider A, Stahl M, Fritzsching E, Sommerburg O, Ley S, Sumkauskaite M, Biederer J, Kauczor HU, Eichinger M, Mall MA.

Am J Respir Crit Care Med. 2014 Apr 15;189(8):956-65. doi: 10.1164/rccm.201309-1659OC.

PMID:
24564281
[PubMed - indexed for MEDLINE]
4.

Summarizing EC50 estimates from multiple dose-response experiments: a comparison of a meta-analysis strategy to a mixed-effects model approach.

Jiang X, Kopp-Schneider A.

Biom J. 2014 May;56(3):493-512. doi: 10.1002/bimj.201300123. Epub 2014 Jan 29.

PMID:
24478144
[PubMed - in process]
5.

GRHL1 acts as tumor suppressor in neuroblastoma and is negatively regulated by MYCN and HDAC3.

Fabian J, Lodrini M, Oehme I, Schier MC, Thole TM, Hielscher T, Kopp-Schneider A, Opitz L, Capper D, von Deimling A, Wiegand I, Milde T, Mahlknecht U, Westermann F, Popanda O, Roels F, Hero B, Berthold F, Fischer M, Kulozik AE, Witt O, Deubzer HE.

Cancer Res. 2014 May 1;74(9):2604-16. doi: 10.1158/0008-5472.CAN-13-1904. Epub 2014 Jan 13.

PMID:
24419085
[PubMed - indexed for MEDLINE]
6.

Comparison of PET/CT and PET/MRI hybrid systems using a 68Ga-labelled PSMA ligand for the diagnosis of recurrent prostate cancer: initial experience.

Afshar-Oromieh A, Haberkorn U, Schlemmer HP, Fenchel M, Eder M, Eisenhut M, Hadaschik BA, Kopp-Schneider A, Röthke M.

Eur J Nucl Med Mol Imaging. 2014 May;41(5):887-97. doi: 10.1007/s00259-013-2660-z. Epub 2013 Dec 19.

PMID:
24352789
[PubMed - in process]
7.

The role of perfusion effects in monitoring of chemoradiotherapy of rectal carcinoma using diffusion-weighted imaging.

Ganten MK, Schuessler M, Bäuerle T, Muenter M, Schlemmer HP, Jensen A, Brand K, Dueck M, Dinkel J, Kopp-Schneider A, Fritzsche K, Stieltjes B.

Cancer Imaging. 2013 Dec 11;13(4):548-56. doi: 10.1102/1470-7330.2013.0045.

PMID:
24334520
[PubMed - in process]
Free PMC Article
8.

Evaluation of the ESUR PI-RADS scoring system for multiparametric MRI of the prostate with targeted MR/TRUS fusion-guided biopsy at 3.0 Tesla.

Roethke MC, Kuru TH, Schultze S, Tichy D, Kopp-Schneider A, Fenchel M, Schlemmer HP, Hadaschik BA.

Eur Radiol. 2014 Feb;24(2):344-52. doi: 10.1007/s00330-013-3017-5. Epub 2013 Oct 3. Erratum in: Eur Radiol. 2014 Apr;24(4):967.

PMID:
24196383
[PubMed - in process]
9.

Validation of Fourier decomposition MRI with dynamic contrast-enhanced MRI using visual and automated scoring of pulmonary perfusion in young cystic fibrosis patients.

Bauman G, Puderbach M, Heimann T, Kopp-Schneider A, Fritzsching E, Mall MA, Eichinger M.

Eur J Radiol. 2013 Dec;82(12):2371-7. doi: 10.1016/j.ejrad.2013.08.018. Epub 2013 Aug 23.

PMID:
24016829
[PubMed - indexed for MEDLINE]
10.

Transcriptomic hepatotoxicity signature of chlorpromazine after short- and long-term exposure in primary human sandwich cultures.

Parmentier C, Truisi GL, Moenks K, Stanzel S, Lukas A, Kopp-Schneider A, Alexandre E, Hewitt PG, Mueller SO, Richert L.

Drug Metab Dispos. 2013 Oct;41(10):1835-42. doi: 10.1124/dmd.113.052415. Epub 2013 Aug 2.

PMID:
23913027
[PubMed - indexed for MEDLINE]
11.

MYCN and HDAC2 cooperate to repress miR-183 signaling in neuroblastoma.

Lodrini M, Oehme I, Schroeder C, Milde T, Schier MC, Kopp-Schneider A, Schulte JH, Fischer M, De Preter K, Pattyn F, Castoldi M, Muckenthaler MU, Kulozik AE, Westermann F, Witt O, Deubzer HE.

Nucleic Acids Res. 2013 Jul;41(12):6018-33. doi: 10.1093/nar/gkt346. Epub 2013 Apr 26.

PMID:
23625969
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Stochastic time-concentration activity models for cytotoxicity in 3D brain cell cultures.

Renner M, Zurich MG, Kopp-Schneider A.

Theor Biol Med Model. 2013 Mar 14;10:19. doi: 10.1186/1742-4682-10-19.

PMID:
23497233
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Biological and tumor-promoting effects of dioxin-like and non-dioxin-like polychlorinated biphenyls in mouse liver after single or combined treatment.

Rignall B, Grote K, Gavrilov A, Weimer M, Kopp-Schneider A, Krause E, Appel KE, Buchmann A, Robertson LW, Lehmler HJ, Kania-Korwel I, Chahoud I, Schwarz M.

Toxicol Sci. 2013 May;133(1):29-41. doi: 10.1093/toxsci/kft034. Epub 2013 Mar 1.

PMID:
23457121
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Accuracy and variability of semiautomatic centerline analysis versus manual aortic measurement techniques for TEVAR.

Müller-Eschner M, Rengier F, Partovi S, Weber TF, Kopp-Schneider A, Geisbüsch P, Kauczor HU, von Tengg-Kobligk H.

Eur J Vasc Endovasc Surg. 2013 Mar;45(3):241-7. doi: 10.1016/j.ejvs.2012.12.003. Epub 2013 Jan 11.

PMID:
23318135
[PubMed - indexed for MEDLINE]
Free Article
15.

Data management in large-scale collaborative toxicity studies: how to file experimental data for automated statistical analysis.

Stanzel S, Weimer M, Kopp-Schneider A.

Toxicol In Vitro. 2013 Jun;27(4):1402-9. doi: 10.1016/j.tiv.2012.12.009. Epub 2012 Dec 20.

PMID:
23261646
[PubMed - indexed for MEDLINE]
16.

Diffusion-weighted imaging in rectal carcinoma patients without and after chemoradiotherapy: a comparative study with histology.

Bäuerle T, Seyler L, Münter M, Jensen A, Brand K, Fritzsche KH, Kopp-Schneider A, Schüssler M, Schlemmer HP, Stieltjes B, Ganten M.

Eur J Radiol. 2013 Mar;82(3):444-52. doi: 10.1016/j.ejrad.2012.10.012. Epub 2012 Dec 4.

PMID:
23219191
[PubMed - indexed for MEDLINE]
17.

Selection of test methods to be included in a testing strategy to predict acute oral toxicity: an approach based on statistical analysis of data collected in phase 1 of the ACuteTox project.

Kinsner-Ovaskainen A, Prieto P, Stanzel S, Kopp-Schneider A.

Toxicol In Vitro. 2013 Jun;27(4):1377-94. doi: 10.1016/j.tiv.2012.11.010. Epub 2012 Nov 21.

PMID:
23178337
[PubMed - indexed for MEDLINE]
18.

Multimodal hypoxia imaging and intensity modulated radiation therapy for unresectable non-small-cell lung cancer: the HIL trial.

Askoxylakis V, Dinkel J, Eichinger M, Stieltjes B, Sommer G, Strauss LG, Dimitrakopoulou-Strauss A, Kopp-Schneider A, Haberkorn U, Huber PE, Bischof M, Debus J, Thieke C.

Radiat Oncol. 2012 Sep 14;7:157. doi: 10.1186/1748-717X-7-157.

PMID:
22974533
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Natural variants in the major neutralizing epitope of human papillomavirus minor capsid protein L2.

Seitz H, Schmitt M, Böhmer G, Kopp-Schneider A, Müller M.

Int J Cancer. 2013 Feb 1;132(3):E139-48. doi: 10.1002/ijc.27831. Epub 2012 Oct 3.

PMID:
22961598
[PubMed - indexed for MEDLINE]
20.

Evaluation of aggregating brain cell cultures for the detection of acute organ-specific toxicity.

Zurich MG, Stanzel S, Kopp-Schneider A, Prieto P, Honegger P.

Toxicol In Vitro. 2013 Jun;27(4):1416-24. doi: 10.1016/j.tiv.2012.06.018. Epub 2012 Aug 29.

PMID:
22954530
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk